Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Molecular characterization of antimicrobial resistant Pseudomonas aeruginosa isolates in tertiary care hospital, Kathmandu

PROVIDER: PRJNA1149775 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR30298176_1.fastq.gz	Fastqsanger.gz
	SRR30298176_2.fastq.gz	Fastqsanger.gz
	SRR30298177_1.fastq.gz	Fastqsanger.gz
	SRR30298177_2.fastq.gz	Fastqsanger.gz
	SRR30298178_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 10

Similar Datasets

Pseudomonas aeruginosa

Project description:Pseudomonas aeruginosa isolates from a tertiary care hospital in South India

| PRJNA698544 | ENA

Project description:Whole genome sequencing for molecular characterization of carbapenem resistant Pseudomonas aeruginosa isolated from a tertiary care hospital of Bihar.

| PRJNA776983 | ENA

Epinecidin-1 has immunomodulatory effects, facilitating its therapeutic use in a mouse model of Pseudomonas aeruginosa sepsis

Project description:Antimicrobial peptides (AMPs) are garnering attention as possible alternatives to antibiotics. Here, we describe the antimicrobial properties of epinecidin-1 against multi-drug resistant clinical isolates of P. aeruginosa (P. aeruginosa (R)) and P. aeruginosa from ATCC (P. aeruginosa (19660)) in vivo. The minimum inhibitory concentrations (MICs) of epinecidin-1 against P. aeruginosa (R) and P. aeruginosa (19660) were determined, and compared with those of imipenem. Epinecidin-1 was found to be highly effective at combating peritonitis infection caused by P. aeruginosa (R) or P. aeruginosa (19660) in mouse models, without inducing adverse behavioral effects, or liver or kidney toxicity. Taken together, our results indicate that epinecidin-1 enhances the survival rate of mice infected with the bacterial pathogen P. aeruginosa through both antimicrobial and immunomodulatory effects.

2014-05-27 | GSE57976 | GEO

Epinecidin-1 has immunomodulatory effects, facilitating its therapeutic use in a mouse model of Pseudomonas aeruginosa sepsis

2014-05-27 | E-GEOD-57976 | biostudies-arrayexpress

Enterobacter

Project description:Molecular characterization of IMP-1 producing Enterobacter cloacae complex isolates in multi tertiary care hospital in Tokyo, Japan

| PRJDB6127 | ENA

Project description:Whole genome sequencing for molecular characterization of carbapenem resistant E.coli isolated from a tertiary care hospital of Bihar.

| PRJNA773853 | ENA

Project description:Whole genome sequencing for molecular characterization of carbapenem resistant Klebsiella pneumoniae isolated from a tertiary care hospital of Bihar.

| PRJNA757582 | ENA

Project description:Whole genome sequencing for molecular characterization of carbapenem resistant Acinetobacter baumannii isolated from a tertiary care hospital of Bihar.

| PRJNA777390 | ENA

Project description:Whole genome sequencing for molecular characterization of carbapenem resistant Staphylococcus aureus isolated from a tertiary care hospital of Bihar.

| PRJNA777395 | ENA

Exploring the diversity and antibiogram of the soil around a tertiary care hospital and a university precinct in southern In-dia: A pilot study

Project description:This study identified and compared the bacterial diversity and the antimicrobial resistance profile of clinically relevant isolates around a newly developed hospital and university precinct

2024-02-27 | GSE225419 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data